INBIOGEN Co., Ltd. (KRX:101140)

INBIOGEN Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,148	5,716	6,089	9,290	23,152	9,114
Trading Asset Securities	-	-	-	-	-	69,920
Cash & Short-Term Investments	4,148	5,716	6,089	9,290	23,152	79,035
Cash Growth	-31.99%	-6.12%	-34.45%	-59.88%	-70.71%	181.84%
Accounts Receivable	3,491	3,285	4,182	5,494	6,233	4,854
Other Receivables	198.86	143.02	87.24	155.77	302.59	582.46
Receivables	3,690	3,428	4,269	5,650	6,575	5,436
Inventory	93.92	111.03	876.6	1,532	1,482	1,014
Prepaid Expenses	20.6	9.35	18.85	43.3	83.18	54.44
Other Current Assets	18.38	15.4	77.87	218.98	609.84	308.44
Total Current Assets	7,971	9,280	11,332	16,733	31,902	85,847
Property, Plant & Equipment	1,130	1,186	2,595	3,691	4,361	1,118
Long-Term Investments	151,232	148,404	126,236	116,798	232,141	5,000
Other Intangible Assets	152.3	190.82	649.38	510.97	462.59	535.87
Long-Term Accounts Receivable	3,302	2,940	2,130	3,486	4,363	3,730
Other Long-Term Assets	295.79	729.27	2,762	3,064	1,245	649.08
Total Assets	164,082	162,730	145,704	144,284	274,475	96,881
Accounts Payable	562.18	684.25	317.9	308.8	646.11	558.76
Accrued Expenses	341.17	403.38	401.12	346.01	605.07	488.94
Short-Term Debt	-	-	-	934.13	11,631	4,241
Current Portion of Leases	231.5	227.03	263.69	286.9	714.79	284.45
Other Current Liabilities	628.92	802.02	1,131	1,934	14,246	12,560
Total Current Liabilities	1,764	2,117	2,114	3,810	27,843	18,133
Long-Term Leases	608.43	667.76	329.57	553.26	1,064	245.58
Long-Term Deferred Tax Liabilities	-	-	-	-	16,953	-
Other Long-Term Liabilities	93.44	109.11	176.96	484.99	660.23	596.44
Total Liabilities	2,466	2,894	2,621	4,848	46,521	18,975
Common Stock	5,022	5,022	5,022	70,442	26,698	25,781
Additional Paid-In Capital	136,123	136,123	136,123	141,607	139,272	134,246
Retained Earnings	22,101	20,070	3,935	-102,829	14,389	-79,736
Treasury Stock	-2,448	-2,448	-2,448	-2,385	-2,385	-2,385
Comprehensive Income & Other	817.32	1,069	449.87	48.4	48.4	0
Total Common Equity	161,616	159,836	143,083	106,884	178,022	77,906
Shareholders' Equity	161,617	159,837	143,083	139,436	227,954	77,906
Total Liabilities & Equity	164,082	162,730	145,704	144,284	274,475	96,881
Total Debt	839.93	894.79	593.26	1,774	13,410	4,771
Net Cash (Debt)	3,308	4,821	5,496	7,515	9,742	74,263
Net Cash Growth	-40.48%	-12.27%	-26.87%	-22.85%	-86.88%	308.88%
Net Cash Per Share	331.33	482.88	645.77	2072.63	3260.05	35929.46
Filing Date Shares Outstanding	9.98	9.98	9.98	6.99	2.62	2.53
Total Common Shares Outstanding	9.98	9.98	9.98	6.99	2.62	2.53
Working Capital	6,207	7,164	9,218	12,924	4,059	67,715
Book Value Per Share	16186.29	16007.99	14330.10	15287.73	68023.15	30849.94
Tangible Book Value	161,464	159,645	142,433	106,373	177,560	77,370
Tangible Book Value Per Share	16171.03	15988.88	14265.07	15214.65	67846.39	30637.74
Machinery	342.37	978.58	1,067	1,123	1,073	122.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.